Filter
1107
Filtered Results: 1107
Text search:
P.
Silva
Featured
Recommendations
77
New Publications
167
Language
Document type
No document type
454
Studies & Reports
330
Guidelines
174
Manuals
66
Strategic & Response Plan
35
Fact sheets
20
Training Material
13
Situation Updates
6
Resource Platforms
4
Brochures
2
App
1
Infographics
1
Online Courses
1
Countries / Regions
Latin America and the Carribbean
105
Brazil
78
Global
73
Mozambique
20
Colombia
18
Venezuela
16
Western and Central Europe
16
El Salvador
15
Russia
14
Africa
12
Philippines
11
India
11
Peru
10
Paraguay
10
Indonesia
10
Ecuador
10
Germany
9
North America
9
Argentina
9
Eastern Europe
9
South Sudan
9
Mexico
7
Ethiopia
7
Kenya
6
Syria
6
Nigeria
6
Asia
6
Bolivia
6
South Africa
6
Vietnam
6
Yemen
6
Nepal
5
Ukraine
5
Chile
5
Spain
5
Honduras
5
Angola
5
Liberia
5
Guatemala
5
Sierra Leone
4
Malawi
4
Tanzania
4
Middle East and North Africa
4
Burkina Faso
3
West and Central Africa
3
Eastern Europe and Central Asia
3
Portugal
3
Uganda
3
Nicaragua
3
Namibia
3
Zambia
3
North Macedonia
2
Turkey
2
China
2
Rwanda
2
Cameroon
2
Afghanistan
2
Guinea
2
Guinea-Bissau
2
Congo, Democratic Republic of
2
Uruguay
2
France
2
United Kingdom
2
Bangladesh
2
Sudan
2
Mali
2
Chad
2
Myanmar / Burma
2
Timor Leste/ East Timor
1
Thailand
1
Ghana
1
Benin
1
Kazakhstan
1
Canada
1
Laos
1
Niger
1
Italy
1
Armenia
1
Haiti
1
Cambodia
1
Dominican Republic
1
Jordan
1
Saudi Arabia
1
Turkmenistan
1
Belgium
1
Belarus
1
Israel
1
Côte d’Ivoire / Ivory Coast
1
Lebanon
1
Moldova
1
Sri Lanka
1
Palestine
1
Georgia
1
Central African Republic
1
Somalia
1
Madagascar
1
Cuba
1
Authors & Publishers
Publication Years
Category
Countries
318
Clinical Guidelines
102
Public Health
91
Women & Child Health
74
Key Resources
39
Capacity Building
13
Pharmacy & Technologies
7
Toolboxes
COVID-19
165
Mental Health
144
NTDs
100
HIV
80
TB
74
Planetary Health
61
Disability
41
NCDs
40
Rapid Response
35
AMR
29
Zika
26
Caregiver
20
Refugee
19
Natural Hazards
17
Global Health Education
17
Health Financing Toolbox
15
Conflict
15
Ebola & Marburg
10
Pharmacy
8
Specific Hazards
7
Malaria
6
Social Ethics
5
Polio
4
Cholera
2
Typhoon
1
Conference Report Sao Paulo, Brazil 22-24 October 2015
Tema 8.22 da agenda provisória
Washington, D.C., EUA, 23 a 27 de setembro de 2018
CD56/INF/22 31 de agosto de 2018
Original: inglês/espanhol
La vigilancia de la resistencia a los antimicrobianos (RAM) desempeña un papel importante en la detección temprana de cepas resistentes que revisten gran importancia para la salud pública, así como en la respuesta rápida a los brotes en los hospitales y en la comunidad. Los resultados de la vig...
Parasites & Vectors volume 11, Article number: 264 (2018)
Dengue creates a staggering epidemiological and economic burden for endemic countries. Without a specific therapy and with a commercial vaccine that presents some problems relative to its full effectiveness, initiatives to improve vector...
The burden of diabetes is enormous, positioning it as one of the main challenges facing public health today. Currently, it is estimated that 62 million people are living with diabetes in the Region of the Americas and projections show its prevalence will continue rising over the following years. The...
El objetivo de esta nota conceptual y del marco que describe es la eliminación de un grupo de enfermedades transmisibles y los efectos negativos sobre la salud que generan que juntos crean una carga tangible en las personas afectadas, sus familias y comunidades, y en los sistemas de atención de sa...
An Indicator-based Approach - This manual presents an indicator-based approach for rapidly assessing pharmaceutical management systems and programs. The manual contains a set of 46 indicators of performance, grouped under eight topics of pharmaceutical management, with each topic being covered by a ...
Pneumonia kills more children than any other illness – more than AIDS, malaria and measles combined. Over 2 million children die from pneumonia each year, accounting for almost 1 in 5 under five deaths worldwide. Yet, little attention is paid to this disease. This joint UNICEF/WHO report examines ...
A book of methods, aids, and ideas for instructors at the village level
An indispensable resource for health educators, this book provides hundreds of methods, aids, and learning strategies to make health education engaging and effective, encouraging community involvement through participatory edu...
This is the third guidance note in a four-part series of notes related to impact evaluation developed by InterAction with financial support from the Rockefeller Foundation.This third guidance note, Introduction to Mixed Methods in Impact Evaluation, starts by explaining what a mixed methods (MM) imp...
Desde Atencion primaria de salud
This report is jointly released by the Human Rights Division (HRD)
of the United Nations Mission in South Sudan (UNMISS) and the Office of the United Nations High Commissioner for Human Rights (OHCHR) and focuses on the right to freedom of opinion and expression in South Sudan.
It covers the per...
Globally, in low-income countries, the average newborn mortality rate is 27 deaths per 1,000 births, the report says. In high-income countries, that rate is 3 deaths per 1,000. Newborns from the riskiest places to give birth are up to 50 times more likely to die than those from the safest places....
As of October 2017, the global database comprised almost 30 000 records, including results from bioassays to measure phenotypic resistance, and biochemical and molecular tests for resistance mechanisms. The current report presents an overview of data on malaria vector resistance for 2010 to 2016. It...
Epilepsy: a public health imperative
recommended
This is the first global report on epilepsy summarizing the available evidence on the burden of epilepsy and the public health response required at global, regional and national levels.
The reports highlights major gaps in awareness, diagnosis, treatment, and health policies through a series of a...
21 January 2022
The overall threat posed by Omicron largely depends on four key questions: (i) how transmissible the variant is; (ii) how well vaccines and prior infection protect against infection, transmission, clinical disease and death; (iii) how virulent the variant is compared to other varian...
